MedTrace Logo

Choroidal Changes Post Short Term Exposure To Virtual Reality Devices

NCT04140877 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-06-04

No results posted yet for this study

Summary

This is a prospective, randomized, controlled, contralateral eye, clinical study. The objective of the study is to determine the impact of Virtual Reality (VR) usage on choroidal thickness when viewed through a test display compared to a control (standard) VR display. The hypothesis is that there will be less choroidal thinning in the eye viewing the test VR screen compared to the eye viewing the control VR screen.

Conditions

  • Myopia

Interventions

DEVICE

Visu

An experimental (test) virtual reality display

Sponsors & Collaborators

  • Visu, Inc.

    lead INDUSTRY

Principal Investigators

  • Lyndon Jones, PhD, FCOptom · Centre for Ocular Research and Education

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2020-12-31
Completion
2021-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04140877 on ClinicalTrials.gov